Recrutamento encerrado
FASE
Número Europeu 2019-003777-26
ROSY-O
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib and Are Judged by the Investigator to Clinically Benefit From Continued Treatment
Detalhes
Destaques